Detalhe da pesquisa
1.
Effect of single agent high-dose methotrexate-related acute kidney injury on length of hospitalization and relative dose intensity in adult patients with central nervous system lymphoma.
J Oncol Pharm Pract
; 23(7): 496-501, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27543094
2.
Reduced time for urinary alkalinization before high-dose methotrexate with preadmission oral bicarbonate.
J Oncol Pharm Pract
; 18(2): 239-44, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22075004
3.
Phase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus as first-line treatment for patients with glioblastoma.
Clin Adv Hematol Oncol
; 10(4): 240-6, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22706484
4.
Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine.
Clin Cancer Res
; 28(24): 5306-5316, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36222848
5.
Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter trial of the AIDS Malignancy Consortium.
Cancer
; 112(5): 1083-8, 2008 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18224669
6.
Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma.
Cancer
; 106(10): 2171-80, 2006 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16598756